Managing Modern Slavery Risk in MedTech
MTAA is proud to present this one-hour webinar on Managing Modern Slavery Risk in MedTech: Practical Tools, Levers and Next Steps.
Modern slavery risk management and due diligence expectations are evolving rapidly across healthcare procurement and global medical technology supply chains. For many MTAA members, including distributors, importers and Australian subsidiaries of global manufacturers, understanding what this means in practice, and what can be influenced locally, can be challenging.
Increasingly, healthcare buyers and government procurement bodies are seeking clearer evidence of due diligence, supplier engagement and risk management, reflecting a broader shift beyond reporting toward more robust and demonstrable approaches to managing modern slavery risk, including in a way that moves from compliance to real world impact.
This practical webinar will help MedTech suppliers understand where risk typically sits, what buyers and regulators expect, and how local teams can respond in a credible and proportionate way.
Participants will gain practical insight into the business case, internal levers, and realistic steps they can take to strengthen procurement readiness and risk management.
Understanding
- Why modern slavery matters for local suppliers
- Evolving compliance and procurement requirements
- Understanding risk hot spots for MedTech
- What suppliers can control and leverage to influence internal business decisions addressing modern slavery
- What ‘good’ practice looks like and a Mini Case Study
Learning Outcomes
- Equipping MedTech suppliers with a baseline understanding of current and future changes to modern slavery regulation.
- Foundational tools and practices for MedTech suppliers operating in Australia to prepare and better manage modern slavery risks.
- Understanding best practice through case studies.
Your Speakers
- Heather Chai, Founder and Principal, Seed and Signal
- Pravin Siriwardena, Policy Manager, MTAA
Who Should Attend
MedTech Environmental, Social and Governance (ESG) professionals, representatives with an interest in sustainability/ESG, or representatives where ESG is a part of your professional role.
Please note: This webinar will be recorded and may be shared in the future at the discretion of the MTAA and that by registering for this event you agree to MTAA's Terms and Conditions and MTAA's Privacy Policy.
Contact Information
Additional Information
Speakers
Heather Chai is Founder and Principal of Seed & Signal, an advisory practice specialising in modern slavery risk management, sustainability strategy and social impact governance. She works with organisations to strengthen human rights due diligence, supply chain risk management and sustainability strategy in response to evolving regulatory, procurement and stakeholder expectations.
Heather previously served as Director of the Modern Slavery Unit at the University of Sydney, where she led the University’s modern slavery and human rights strategy across procurement, research and operations. She is a former Australian diplomat with experience in international development and public diplomacy across the Indo-Pacific.
Heather is also a UNDP SDG Impact Standards Accredited Trainer, Chair of Results International Australia, and a sessional academic at Macquarie University Business School. Her work focuses on helping organisations move beyond reporting to strengthen governance, capability and impact and accountability in managing modern slavery risk.
Pravin Siriwardena is the Medical Technology Association of Australia’s (MTAA) policy lead for Environmental, Social and Governance (ESG) and procurement. He plays a key role in advocating for harmonised approaches to ESG policy across the MedTech ecosystem and serves as the Australian representative on the Global Medical Technology Alliance (GMTA) Sustainability Committee. Pravin has also presented on the evolving ESG landscape within the medical technology sector at major international forums across Europe and the Asia–Pacific region. He holds a Bachelor of Medical Science from the University of Sydney, a Master of Public Health from the University of Melbourne and is currently completing a Master of Business Administration (MBA) at the University of Sydney.
